ClosedResearch2026
Cochrane Funding Program 2026
National Health and Medical Research Council (NHMRC) · Australia
The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.
Funding
$6.5M – $6.5M
Closed
1 May 2026
Duration
up to 4 years
Location
Australia
Who Can Apply
• Applications will only be accepted from NHMRC approved Administering Institutions.
• Applications must satisfy all the requirements set out in the Cochrane Funding 2026 Grant Guidelines.
• This grant is only available to Cochrane Australia.
Applications will only be accepted from NHMRC approved Administering Institutions. Applications must satisfy all the requirements set out in the Cochrane Funding 2026 Grant Guidelines. This grant is only available to Cochrane Australia.
What's Funded
Production of Cochrane systematic reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making and translation of research into policy, health systems and clinical practice.Expected Outcomes
Australian Cochrane review production and evidence synthesis outputs that inform healthcare decision making, with grants announced in July 2026 and research outputs delivered for up to four years from commencement.Key Information
Applicant Types
universityother
Stage
any
Funding Purposes
researchcommunityother
Keywords
Cochranemedical researchevidence synthesissystematic reviewshealthcare decision makingNHMRCevidence-based practice
Frequently Asked Questions
1
What is the Cochrane Funding Program 2026?
The Cochrane Funding Program 2026 is a research grant offered by National Health and Medical Research Council (NHMRC) in Australia, providing $6.5M – $6.5M in funding. The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making.
2
How much funding does the Cochrane Funding Program 2026 provide?
The Cochrane Funding Program 2026 provides $6.5M – $6.5M in funding. The typical project duration is up to 4 years.
3
Who is eligible for the Cochrane Funding Program 2026?
- Applications will only be accepted from NHMRC approved Administering Institutions.
- Applications must satisfy all the requirements set out in the Cochrane Funding 2026 Grant Guidelines.
- This grant is only available to Cochrane Australia.
4
When does the Cochrane Funding Program 2026 close?
Applications closed on 1 May 2026.
5
What activities are funded?
Production of Cochrane systematic reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making and translation of research into policy, health systems and clinical practice.
6
How do I apply for the Cochrane Funding Program 2026?
Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.
Need help applying?
Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.